ALFREDO RIVAS DELGADO



DATOS GENERALES
Nombre completo   ALFREDO RIVAS DELGADO
Máximo nivel de estudios   LICENCIATURA
Antigüedad académica en la UNAM   6 años
NOMBRAMIENTOS
Último  PROFESOR ASIGNATURA A TP No Definitivo
Facultad de Medicina
PROFESOR ASIGNATURA A TP No Definitivo
Facultad de Medicina
Desde 01-11-2009 hasta 31-03-2010
AYUDANTE PROFESOR A TP No Definitivo
Facultad de Medicina
Desde 01-01-2008 (fecha inicial de registros en el SIIA) hasta 30-10-2009
ESTIMULOS, PROGRAMAS, PREMIOS Y RECONOCIMIENTOS
NO CUENTA CON ESTIMULOS, PROGRAMAS, PREMIOS Y RECONOCIMIENTOS

INFORMACIÓN DE PUBLICACIONES
Firmas  
Delgado A.R. Rivas, A Rivas-delgado A.
ID's SCOPUS  
36573969400
ORCID's  
0000-0003-0385-3415
Áreas de conocimiento  
Biochemistry and molecular biology Cell biology Endocrinology & metabolism Hematology Medicine, general and internal
Multidisciplinary sciences Oncology Surgery Anesthesiology and pain medicine Biochemistry, genetics and molecular biology (miscellaneous)
Cancer research Clinical biochemistry Endocrinology, Diabetes and Metabolism Hematology Medicine (miscellaneous)
Oncology Physics and astronomy (miscellaneous) Surgery
Coautorías con entidades de la UNAM  
Revistas en las que ha publicado  (22):
  1. AM J HEMATOL, Estados Unidos America (2017)
  2. ANNALS OF HEMATOLOGY, Estados Unidos America (2021)
  3. ANNALS OF ONCOLOGY, Reino Unido (2017, 2019)
  4. Blood Advances, Estados Unidos America (2020)
  5. BLOOD CANCER J, Reino Unido (2018, 2020)
  6. BRITISH JOURNAL OF HAEMATOLOGY, Estados Unidos America (2016, 2018, 2019, 2021, 2022)
  7. Cancers, Suiza (2021)
  8. CELL REPORTS, Estados Unidos America (2022)
  9. CLINICAL CANCER RESEARCH, Estados Unidos America (2021)
  10. Diabetes Care, Estados Unidos America (2010)
  11. Diagnostics, Suiza (2022)
  12. EUROPEAN JOURNAL OF HAEMATOLOGY, Estados Unidos America (2021)
  13. HAEMATOLOGICA, Italia (2017, 2020, 2021)
  14. HEMATOL ONCOL, Reino Unido (2021, 2022)
  15. Leukemia, Reino Unido (2021)
  16. LEUKEMIA & LYMPHOMA, Reino Unido (2021, 2022)
  17. LEUKEMIA RESEARCH, Reino Unido (2017, 2020)
  18. Nature Cancer, Alemania (2020)
  19. NATURE COMMUNICATIONS, Reino Unido (2020)
  20. NATURE MEDICINE, Estados Unidos America (2022)
  21. OBESITY SURGERY, Estados Unidos America (2013)
  22. Oncotarget, Estados Unidos America (2017)


Descargar PDF

Documentos indexados (WoS y Scopus)

# Título del documento Autores Año Revista Fuente Citas WoS Citas Scopus
1Clinico-biological features and outcome of patients with splenic marginal zone lymphoma with histological transformationCoautor: Rivas-delgado A., Bastidas-Mora G., Beà S., Navarro A., et al.2022BRITISH JOURNAL OF HAEMATOLOGYWoS-id: 000695434400001
Scopus-id: 2-s2.0-85114837883
2222
2Revised International Prognostic Index and genetic alterations are associated with early failure to R-CHOP in patients with diffuse large B-cell lymphomaCoautor: Rivas-delgado A., Dlouhy I., Karube K., Enjuanes A., et al.2022BRITISH JOURNAL OF HAEMATOLOGYWoS-id: 000705122500001
Scopus-id: 2-s2.0-85116797465
56
3The Prognostic Nutritional Index (PNI) is an independent predictor of overall survival in older patients with follicular lymphomaCoautor: Rivas-delgado A., Mozas P., Rivero A., Nadeu F., et al.2022LEUKEMIA & LYMPHOMAWoS-id: 000724056800001
Scopus-id: 2-s2.0-85120358432
88
4First external validation of the FLIPI-L score in a single-center series of patients with follicular lymphomaCoautor: Rivas-delgado A., Mozas P., Rivero A., Correa J.G., et al.2022HEMATOL ONCOLWoS-id: 000727565600001
Scopus-id: 2-s2.0-85120635768
00
5Oncogenic Vav1-Myo1f induces therapeutically targetable macrophage-rich tumor microenvironment in peripheral T cell lymphomaCoautor: Rivas-delgado A., Cortes J.R., Filip I., Albero R., et al.2022CELL REPORTSWoS-id: 000792276800005
Scopus-id: 2-s2.0-85128399799
1419
6Cell-Free DNA for Genomic Analysis in Primary Mediastinal Large B-Cell Lymphoma1ᵉʳ autor: Rivas-delgado A., Nadeu F., Andrade-Campos M., López C., et al.2022DiagnosticsWoS-id: 000833104700001
Scopus-id: 2-s2.0-85133502761
1013
7Detection of early seeding of Richter transformation in chronic lymphocytic leukemiaCoautor: Rivas-delgado A., Nadeu F., Royo R., Massoni-Badosa R., et al.2022NATURE MEDICINEWoS-id: 000839575100002
Scopus-id: 2-s2.0-85135812673
8382
8A low lymphocyte-to-monocyte ratio is an independent predictor of poorer survival and higher risk of histological transformation in follicular lymphomaCoautor: Rivas-delgado A., Mozas P., Rivero A., Nadeu F., et al.2021LEUKEMIA & LYMPHOMAWoS-id: 000571323400001
Scopus-id: 2-s2.0-85091171625
1010
9Baseline correlations and prognostic impact of serum monoclonal proteins in follicular lymphomaCoautor: Rivas-delgado A., Mozas P., Rivero A., Fabregat A., et al.2021BRITISH JOURNAL OF HAEMATOLOGYWoS-id: 000589642100001
Scopus-id: 2-s2.0-85096672633
56
10The interval between frontline treatment and the second relapse (PFS2) predicts survival from the second relapse in follicular lymphoma patientsCoautor: Rivas-delgado A., Mozas P., Sorigué M., Rivero A., et al.2021EUROPEAN JOURNAL OF HAEMATOLOGYWoS-id: 000598382100001
Scopus-id: 2-s2.0-85100734648
22
11Mutational landscape and tumor burden assessed by cell-free DNA in diffuse large B-cell lymphoma in a population-based study1ᵉʳ autor: Rivas-delgado A., Nadeu F., Enjuanes A., Casanueva-Eliceiry S., et al.2021CLINICAL CANCER RESEARCHWoS-id: 000617323400019
Scopus-id: 2-s2.0-85100279537
6264
12Age and comorbidity are determining factors in the overall and relative survival of patients with follicular lymphomaCoautor: Rivas-delgado A., Mozas P., Rivero A., Nadeu F., et al.2021ANNALS OF HEMATOLOGYWoS-id: 000621285400001
Scopus-id: 2-s2.0-85101577917
66
13The receptor of the colony-stimulating factor-1 (CSF-1R) is a novel prognostic factor and therapeutic target in follicular lymphomaCoautor: Rivas-delgado A., Valero J.G., Matas-Céspedes A., Arenas F., et al.2021LeukemiaWoS-id: 000629893400002
Scopus-id: 2-s2.0-85102993343
4244
14Serum monoclonal component in chronic lymphocytic leukemia: Baseline correlations and prognostic impactCoautor: Rivas-delgado A., Mozas P., Piñeyroa J.A., Nadeu F., et al.2021HAEMATOLOGICAWoS-id: 000656912200002
Scopus-id: 2-s2.0-85095677107
44
15Clinicobiological characteristics and outcomes of patients with t-cell large granular lymphocytic leukemia and chronic lymphoproliferative disorder of natural killer cells from a single institutionCoautor: Rivas-delgado A., Rivero A., Mozas P., Jiménez L., et al.2021CancersWoS-id: 000681831800001
Scopus-id: 2-s2.0-85111455153
1214
16Prognostic ability of five clinical risk scores in follicular lymphoma: A single-center evaluationCoautor: Rivas-delgado A., Mozas P., Rivero A., Correa J.G., et al.2021HEMATOL ONCOLWoS-id: 000693467500001
Scopus-id: 2-s2.0-85114342484
65
17Patterns of change in treatment, response, and outcome in patients with follicular lymphoma over the last four decades: a single-center experienceCoautor: Rivas-delgado A., Mozas P., Nadeu F., Rivero A., et al.2020BLOOD CANCER JWoS-id: 000518328000001
Scopus-id: 2-s2.0-85081228931
2829
18IgCaller for reconstructing immunoglobulin gene rearrangements and oncogenic translocations from whole-genome sequencing in lymphoid neoplasmsCoautor: Rivas-delgado A., Nadeu F., Mas-de-les-Valls R., Navarro A., et al.2020NATURE COMMUNICATIONSWoS-id: 000548309100009
Scopus-id: 2-s2.0-85087550795
2728
19Cryptic insertions of the immunoglobulin light chain enhancer region near CCND1 in t(11;14)-negative mantle cell lymphomaCoautor: Rivas-delgado A., Fuster C., Martín-Garcia D., Balagué O., et al.2020HAEMATOLOGICAWoS-id: 000555707800007
Scopus-id: 2-s2.0-85084366780
1619
20High serum levels of IL-2R, IL-6, and TNF-a are associated with higher tumor burden and poorer outcome of follicular lymphoma patients in the rituximab era2ᵒ autor: Rivas-delgado A., Mozas P., Rivero A., Dlouhy I., et al.2020LEUKEMIA RESEARCHWoS-id: 000564127700008
Scopus-id: 2-s2.0-85085278703
1213
21PI3Kd inhibition reshapes follicular lymphoma?immune microenvironment cross talk and unleashes the activity of venetoclaxCoautor: Rivas-delgado A., Serrat N., Guerrero-Hernández M., Matas-Céspedes A., et al.2020Blood AdvancesWoS-id: 000567426100019
Scopus-id: 2-s2.0-85091513700
2729
22The proliferative history shapes the DNA methylome of B-cell tumors and predicts clinical outcomeCoautor: Rivas-delgado A., Duran-Ferrer M., Clot G., Nadeu F., et al.2020Nature CancerWoS-id: 000614887500008
Scopus-id: 2-s2.0-85094883634
5357
23Response duration and survival shorten after each relapse in patients with follicular lymphoma treated in the rituximab era1ᵉʳ autor: Rivas-delgado A., Magnano L., Moreno-Velázquez M., García O., et al.2019BRITISH JOURNAL OF HAEMATOLOGYWoS-id: 000458970900008
Scopus-id: 2-s2.0-85057756800
5759
24Life expectancy of follicular lymphoma patients in complete response at 30 months is similar to that of the Spanish general populationCoautor: Rivas-delgado A., Magnano L., Alonso-Alvarez S., Alcoceba M., et al.2019BRITISH JOURNAL OF HAEMATOLOGYWoS-id: 000465109900010
Scopus-id: 2-s2.0-85064479321
2727
25Corrigendum: Dissection of DLBCL microenvironment provides a gene expression-based predictor of survival applicable to formalin-fixed paraffin-embedded tissue (Annals of Oncology (2018) 29 (2363-2370) DOI: 10.1093/annonc/mdy450)Coautor: Rivas-delgado A., Ciavarella S., Vegliante M.C., Fabbri M., et al.2019ANNALS OF ONCOLOGYWoS-id: 000507595800024
Scopus-id: 2-s2.0-85077402370
1313
26Analysis of criteria for treatment initiation in patients with progressive chronic lymphocytic leukemia2ᵒ autor: Rivas-delgado A., Mozas P., Baumann T., Villamor N., et al.2018BLOOD CANCER JWoS-id: 000423723100001
Scopus-id: 2-s2.0-85040837659
43
27Is there a role for minimal residual disease monitoring in the management of patients with hairy-cell leukaemia?Coautor: Rivas-delgado A., Ortiz-Maldonado V., Villamor N., Baumann T., et al.2018BRITISH JOURNAL OF HAEMATOLOGYWoS-id: 000447750900016
Scopus-id: 2-s2.0-85055078425
79
28Chronic lymphocytic leukemia: A prognostic model comprising only two biomarkers (IGHV mutational status and FISH cytogenetics) separates patients with different outcome and simplifies the CLL-IPICoautor: Rivas-delgado A., Delgado J., Doubek M., Baumann T., et al.2017AM J HEMATOLWoS-id: 000399299300022
Scopus-id: 2-s2.0-85012996204
7685
29Patients with chronic lymphocytic leukemia and complex karyotype show an adverse outcome even in absence of TP53/ATM FISH deletionsCoautor: Rivas-delgado A., Puiggros A., Collado R., Calasanz M.J., et al.2017OncotargetWoS-id: 000407826100033
Scopus-id: 2-s2.0-85028629855
3542
30The Bruton tyrosine kinase inhibitor CC-292 shows activity in mantle cell lymphoma and synergizes with lenalidomide and NIK inhibitors depending on nuclear factor-?B mutational statusCoautor: Rivas-delgado A., Vidal-Crespo A., Rodriguez V., Matas-Céspedes A., et al.2017HAEMATOLOGICAWoS-id: 000414069100006
Scopus-id: 2-s2.0-85032698302
1618
31Clinicobiological features and prognostic impact of diffuse large B-cell lymphoma component in the outcome of patients with previously untreated follicular lymphomaCoautor: Rivas-delgado A., Magnano L., Balagué O., Dlouhy I., et al.2017ANNALS OF ONCOLOGYWoS-id: 000414493200024
Scopus-id: 2-s2.0-85034118134
2024
32High serum levels of soluble interleukin-2 receptor (sIL2-R), interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF) are associated with adverse clinical features and predict poor outcome in diffuse large B-cell lymphomaCoautor: Rivas-delgado A., Dlouhy I., Filella X., Rovira J., et al.2017LEUKEMIA RESEARCHWoS-id: 000415601000004
Scopus-id: 2-s2.0-85019365472
4046
33Recurrent pure red cell aplasia in a hepatorenal transplant recipient with chronic parvovirus B19 infection1ᵉʳ autor: Rivas-delgado A., Matutes E., Rozman M.2016BRITISH JOURNAL OF HAEMATOLOGYScopus-id: 2-s2.0-84956947647
06
34Clinical impact of a 6-week preoperative very low calorie diet on body weight and liver size in morbidly obese patientsCoautor: Delgado A.R., González-Pérez J., Sánchez-Leenheer S., González-Vargas L., et al.2013OBESITY SURGERYWoS-id: 000324230800019
Scopus-id: 2-s2.0-84884668997
4041
35Potential Additional Effect of Omentectomy on Metabolic Syndrome, Acute-Phase Reactants, and Inflammatory Mediators in Grade III Obese Patients Undergoing Laparoscopic Roux-en-YCoautor: Rivas, A, Herrera, MF, Pantoja, JP, Velazquez-Fernandez, D, et al.2010Diabetes CareWoS-id: 000282356800002
Scopus-id: 2-s2.0-77958176309
6169
Descargar PDF

Documentos no indexados (Humanindex)

# Título del documento ISSN Revista Año Fuente
Descargar PDF

No se encuentran registros en la base de datos de capítulos de libros (WoS y Scopus).

Descargar PDF

No se encuentran registros en la base de datos de obras con ISBN (Indautor).

Descargar PDF

No se encuentran registros en la base de datos de proyectos.

Descargar PDF

No se encuentran registros en la base de datos de comités de tesis.

Descargar PDF

No se encuentran registros en la base de datos de docencia impartida.

Descargar PDF

No se encuentran registros en la base de datos de patentes.

Descargar PDF

No se encuentran registros en la base de datos de libros completos (Humanindex).

Descargar PDF

Capítulos de libros (Humanindex)

# Título del libro Título del capítulo ISBN Editorial Año Fuente